SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
BSE: 532872
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 39.92-97.8% | 1.9K+21831.6% | 8.45+7.5% | 7.86-18.5% | 9.64-64.5% | 27.19+82.4% | 14.91+15.9% | 12.86 |
| Other Income | 23.66+1214.4% | 1.80 | 0.00-100.0% | 0.01-99.9% | 9.02 | 0.00-100.0% | 0.19+375.0% | 0.04 |
| Total Income | 63.58-96.6% | 1.9K+21852.9% | 8.45+7.4% | 7.87-57.8% | 18.66-31.4% | 27.19+80.1% | 15.10+17.1% | 12.90 |
| EXPENSES | ||||||||
| Expenditure | 84.56-10.3% | 94.32+23.0% | 76.66-8.6% | 83.84+18.6% | 70.69-19.8% | 88.17-7.0% | 94.81-21.4% | 120.59 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | ||||||||
| PBT | -20.98-101.2% | 1.8K+2285.3% | -80.57-6.1% | -75.97-46.0% | -52.03+14.7% | -60.98+23.5% | -79.71+26.0% | -107.69 |
| Net Profit | -20.98-101.2% | 1.8K+2285.3% | -80.57-6.1% | -75.97-46.0% | -52.03+14.7% | -60.98+23.5% | -79.71+26.0% | -107.69 |
| KEY METRICS | ||||||||
| OPM % | -85.95%-181.62pp | 95.67%+195.67pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -33.00%-127.92pp | 94.92%+194.92pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.65-98.8% | 54.26+2087.9% | 2.48+6.0% | 2.34+46.2% | 1.60-14.9% | 1.88+176.4% | -2.46+25.9% | -3.32 |
Corporate Events
Board MeetingSPARC
202610Aug
Board Meeting
The 21st Annual General Meeting ("AGM") of the Company will …
BSE Filing ↗ Board MeetingSPARC
20269Feb
Board Meeting
Consider and approve the Unaudited Standalone and Consolidat…
BSE Filing ↗ Board MeetingSPARC
20254Aug
Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗ Board MeetingSPARC
202519May
Board Meeting
Consider and approve Audited Financial Statements for the ye…
BSE Filing ↗ Board MeetingSPARC
20244Nov
Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗ Board MeetingSPARC
202424May
Board Meeting
Consider and approve audited financial results and propose r…
BSE Filing ↗